Abstract
Bay 12-8039, a new 8-methoxy quinolone, was compared with other agents for activity against clinically relevant anaerobes. Bay 12-8039 inhibited 91 and 96% of the 410 test isolates at 2 and 4 micrograms/ml, respectively. Bay 12-8039 had activity comparable to that metronidazole and overall was at least 16-fold more active than ciprofloxacin, ofloxacin, and cefoxitin, 32-fold more active than cefotetan, and at least 128-fold more active than penicillin G.
Full Text
The Full Text of this article is available as a PDF (57.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aldridge K. E., Gelfand M., Reller L. B., Ayers L. W., Pierson C. L., Schoenknecht F., Tilton R. C., Wilkins J., Henderberg A., Schiro D. D. A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States. Diagn Microbiol Infect Dis. 1994 Apr;18(4):235–241. doi: 10.1016/0732-8893(94)90026-4. [DOI] [PubMed] [Google Scholar]
- Aldridge K. E., Sanders C. V., Lewis A. C., Marier R. L. Susceptibility of anaerobic bacteria to beta-lactam antibiotics and beta-lactamase production. J Med Microbiol. 1983 Feb;16(1):75–82. doi: 10.1099/00222615-16-1-75. [DOI] [PubMed] [Google Scholar]
- Eley A., Greenwood D. Beta-lactamases of type culture strains of the Bacteroides fragilis group and of strains that hydrolyse cefoxitin, latamoxef and imipenem. J Med Microbiol. 1986 Feb;21(1):49–57. doi: 10.1099/00222615-21-1-49. [DOI] [PubMed] [Google Scholar]
- Goldstein E. J. Patterns of susceptibility to fluoroquinolones among anaerobic bacterial isolates in the United States. Clin Infect Dis. 1993 Jun;16 (Suppl 4):S377–S381. doi: 10.1093/clinids/16.supplement_4.s377. [DOI] [PubMed] [Google Scholar]
- Huth R. G., Acebo R., Matthew E. B. Osteitis cystica tuberculosa multiplex in a patient infected with human immunodeficiency virus. Clin Infect Dis. 1994 Feb;18(2):260–261. doi: 10.1093/clinids/18.2.260. [DOI] [PubMed] [Google Scholar]
- Nord C. E., Lindqvist L., Olsson-Liljequist B., Tunér K. Beta-lactamases in anaerobic bacteria. Scand J Infect Dis Suppl. 1985;46:57–63. [PubMed] [Google Scholar]
- Sato K., Matsuura Y., Inoue M., Mitsuhashi S. Properties of a new penicillinase type produced by Bacteroides fragilis. Antimicrob Agents Chemother. 1982 Oct;22(4):579–584. doi: 10.1128/aac.22.4.579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wexler H. M., Molitoris E., Reeves D., Finegold S. M. In vitro activity of DU-6859a against anaerobic bacteria. Antimicrob Agents Chemother. 1994 Oct;38(10):2504–2509. doi: 10.1128/aac.38.10.2504. [DOI] [PMC free article] [PubMed] [Google Scholar]